4 ms·
What ramraj is talking about: if you go into a competitive grad program to get a PhD in structural biology, your advisor will probably expect that in 3-4 years
by dekhn 4y ago
What ramraj is talking about: if you go into a competitive grad program to get a PhD in structural biology, your advisor will probably expect that in 3-4 years you will: crystallize a protein of interest, collect enough data to make a model, and publish that model in a major journal. Many people in my program could not graduate until they had a Nature or Science paper (my advisor was not an asshole, I graduated with just a paper in Biochemistry).
In a sense both of you are right- DeepMind is massively overplaying the value of what they did, trying to expand its impact far beyond what they actually achieved (this is common in competitive biology), but what they did was such an improvement over the state of the art that it's considered a major accomplishment. It also achieved the target of CASP- which was to make predictions whose scores are indistinguishable from experimentally determined structures.
I don't think academics thought CASP was unwinnable but most groups were very surprised that an industrial player using 5 year old tech did so well.
- flobosg 4y agoHear, hear. This is probably the best take.
- lucidrains 4y agoTo add to this, the deep learning field has already moved on towards MSA-less structure prediction. None of this would be possible without building on top of the work open sourced by Deepmind. https://www.biorxiv.org/content/10.1101/2022.07.21.500999v1 https://www.biorxiv.org/content/10.1101/2022.07.21.500999v1 https://www.biorxiv.org/content/10.1101/2022.07.20.500902v1 https://www.biorxiv.org/content/10.1101/2022.07.20.500902v1 To be overly dismissive is to lack imagination.
- tomp 4y agoHow do we know these "MSA-less" models aren't cheating (i.e. learning all MSAs implicitly from their training data)? If they are, they would similarly fail on any "novel" AA sequence (i.e. one without known/learned MSAs)
- valarauko 4y ago> What ramraj is talking about: if you go into a competitive grad program to get a PhD in structural biology, your advisor will probably expect that in 3-4 years you will: crystallize a protein of interest, collect enough data to make a model, and publish that model in a major journal. All of that is generally applicable to molecular biology in general, and I don't see how the field of structural biology is especially egregious, the way ramraj is making it out to be.
- flobosg 4y agoProtein crystallization can be very difficult and there is no general solution. Kits that screen for crystal growth conditions usually help but optimization is needed in most cases. Then, that crystal must have certain properties that allow for good data acquisition at the X-ray facility. That’s another problem by itself and months or years can pass until you get a suitable protein crystal and X-ray diffraction dataset where you can model your structure.
- valarauko 4y agoI'm familiar with protein crystallization and the difficulties associated with it. What I don't agree with is the characterization of the field as especially difficult, above and beyond modern biology in general. Nor can I support the assertion that structural biology students are subject to special abuse that regular grad students are not. > ... can be very difficult and there is no general solution This is true of pretty much any graduate work in molecular biology.
- flobosg 4y ago> Nor can I support the assertion that structural biology students are subject to special abuse that regular grad students are not. I didn’t say anything regarding that. > This is true of pretty much any graduate work in molecular biology. Just to elaborate my point: The process of protein cristallization is not understood at a level that allows the design of general and reproducible protocols. This inherent obscurity means that every new protein needs to undergo an ad hoc, heuristic, iterative process to obtain high quality crystals. This is an early methodological hurdle, at a stage where other routine procedures in biochemistry or molecular biology are usually successful.